1. Home
  2. BBT vs CERT Comparison

BBT vs CERT Comparison

Compare BBT & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBT
  • CERT
  • Stock Information
  • Founded
  • BBT 1846
  • CERT 2008
  • Country
  • BBT United States
  • CERT United States
  • Employees
  • BBT N/A
  • CERT N/A
  • Industry
  • BBT Banks
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • BBT Finance
  • CERT Technology
  • Exchange
  • BBT Nasdaq
  • CERT Nasdaq
  • Market Cap
  • BBT 2.2B
  • CERT 1.9B
  • IPO Year
  • BBT N/A
  • CERT 2020
  • Fundamental
  • Price
  • BBT $24.26
  • CERT $13.25
  • Analyst Decision
  • BBT Hold
  • CERT Buy
  • Analyst Count
  • BBT 1
  • CERT 8
  • Target Price
  • BBT $33.00
  • CERT $15.43
  • AVG Volume (30 Days)
  • BBT 537.9K
  • CERT 2.1M
  • Earning Date
  • BBT 11-08-2025
  • CERT 11-05-2025
  • Dividend Yield
  • BBT 2.26%
  • CERT N/A
  • EPS Growth
  • BBT N/A
  • CERT N/A
  • EPS
  • BBT 0.88
  • CERT 0.05
  • Revenue
  • BBT $345,393,000.00
  • CERT $405,755,000.00
  • Revenue This Year
  • BBT $53.53
  • CERT $11.71
  • Revenue Next Year
  • BBT $73.62
  • CERT $8.14
  • P/E Ratio
  • BBT $27.21
  • CERT $263.44
  • Revenue Growth
  • BBT 8.11
  • CERT 11.61
  • 52 Week Low
  • BBT $22.27
  • CERT $8.64
  • 52 Week High
  • BBT $32.36
  • CERT $15.69
  • Technical
  • Relative Strength Index (RSI)
  • BBT N/A
  • CERT 68.73
  • Support Level
  • BBT N/A
  • CERT $13.01
  • Resistance Level
  • BBT N/A
  • CERT $13.88
  • Average True Range (ATR)
  • BBT 0.00
  • CERT 0.49
  • MACD
  • BBT 0.00
  • CERT 0.19
  • Stochastic Oscillator
  • BBT 0.00
  • CERT 79.62

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: